353 related articles for article (PubMed ID: 31755117)
21. High-Throughput Metabolomics for Discovering Potential Metabolite Biomarkers and Metabolic Mechanism from the APPswe/PS1dE9 Transgenic Model of Alzheimer's Disease.
Yu J; Kong L; Zhang A; Han Y; Liu Z; Sun H; Liu L; Wang X
J Proteome Res; 2017 Sep; 16(9):3219-3228. PubMed ID: 28753016
[TBL] [Abstract][Full Text] [Related]
22. Application of lipidomics to reveal differences of facial skin surface lipids between atopic dermatitis and healthy infants.
Wang H; Cui L; Jia Y; Gao Y; Zhang G; He C
J Cosmet Dermatol; 2020 Jun; 19(6):1528-1534. PubMed ID: 31617666
[TBL] [Abstract][Full Text] [Related]
23. Effect of Chinese herbal compound GAPT on the early brain glucose metabolism of APP/PS1 transgenic mice.
Mana L; Feng H; Dong Y; Wang Y; Shi J; Tian J; Wang P
Int J Immunopathol Pharmacol; 2019; 33():2058738419841482. PubMed ID: 30957587
[TBL] [Abstract][Full Text] [Related]
24. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
[TBL] [Abstract][Full Text] [Related]
25. A Comparative Study of Serum Pharmacochemistry of Kai-Xin-San in Normal and AD Rats Using UPLC-LTQ-Orbitrap-MS.
Yang L; Liang J; Zheng Q; Zhou L; Xiong Y; Wang H; Yuan J
Pharmaceuticals (Basel); 2022 Dec; 16(1):. PubMed ID: 36678527
[TBL] [Abstract][Full Text] [Related]
26. Kai-Xin-San protects against mitochondrial dysfunction in Alzheimer's disease through SIRT3/NLRP3 pathway.
Su S; Chen G; Gao M; Zhong G; Zhang Z; Wei D; Luo X; Wang Q
Chin Med; 2023 Mar; 18(1):26. PubMed ID: 36918872
[TBL] [Abstract][Full Text] [Related]
27. Identifying quality-markers from Shengmai San protects against transgenic mouse model of Alzheimer's disease using chinmedomics approach.
Zhang AH; Yu JB; Sun H; Kong L; Wang XQ; Zhang QY; Wang XJ
Phytomedicine; 2018 Jun; 45():84-92. PubMed ID: 29685366
[TBL] [Abstract][Full Text] [Related]
28. High-throughput metabolomics and ingenuity pathway approach reveals the pharmacological effect and targets of Ginsenoside Rg1 in Alzheimer's disease mice.
Li G; Zhang N; Geng F; Liu G; Liu B; Lei X; Li G; Chen X
Sci Rep; 2019 May; 9(1):7040. PubMed ID: 31065079
[TBL] [Abstract][Full Text] [Related]
29. A Urinary Metabolomics Analysis Based on UPLC-MS and Effects of Moxibustion in APP/PS1 Mice.
He R; Liu J; Huang C; Liu J; Cui H; Zhao B
Curr Alzheimer Res; 2020; 17(8):753-765. PubMed ID: 33167836
[TBL] [Abstract][Full Text] [Related]
30. [Biomarkers related to cognitive dysfunction in APP/PS1 mice based on non-targeted metabonomics and intervention mechanism of Huanglian Jiedu Decoction].
Wang LN; Gu XR; Si N; Wang HJ; Zhou YY; Bian BL; Zhao HY
Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(22):6117-6126. PubMed ID: 36471936
[TBL] [Abstract][Full Text] [Related]
31. UPLC-Q/TOF MS standardized Chinese formula Xin-Ke-Shu for the treatment of atherosclerosis in a rabbit model.
Liu YT; Peng JB; Jia HM; Cai DY; Zhang HW; Yu CY; Zou ZM
Phytomedicine; 2014 Sep; 21(11):1364-72. PubMed ID: 24916703
[TBL] [Abstract][Full Text] [Related]
32. Plasma metabolomics combined with lipidomics profiling reveals the potential antipyretic mechanisms of Qingkailing injection in a rat model.
Qin L; Zhang Z; Guo M; Zhang Q; Wang Q; Lu Z; Zhao H; Liu Y; Fu S; Wang M; Gao X
Chem Biol Interact; 2016 Jul; 254():24-33. PubMed ID: 27208622
[TBL] [Abstract][Full Text] [Related]
33. Application of metabolomics based on direct mass spectrometry analysis for the elucidation of altered metabolic pathways in serum from the APP/PS1 transgenic model of Alzheimer's disease.
González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
J Pharm Biomed Anal; 2015 Mar; 107():378-85. PubMed ID: 25656489
[TBL] [Abstract][Full Text] [Related]
34. Mass spectrometry-based serum lipidomics strategy to explore the mechanism of Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. leaves in the treatment of ischemic stroke.
Wang R; Liu S; Liu T; Wu J; Zhang H; Sun Z; Liu Z
Food Funct; 2021 May; 12(10):4519-4534. PubMed ID: 33890948
[TBL] [Abstract][Full Text] [Related]
35. Lipidomics coupled with pathway analysis characterizes serum metabolic changes in response to potassium oxonate induced hyperuricemic rats.
Yang F; Liu M; Qin N; Li S; Yu M; Wang C; Ma Q
Lipids Health Dis; 2019 May; 18(1):112. PubMed ID: 31077208
[TBL] [Abstract][Full Text] [Related]
36. Lipidomics to investigate the pharmacologic mechanisms of ginkgo folium in the hyperuricemic rat model.
Zhang S; Zhuang J; Yue G; Wang Y; Liu M; Zhang B; Du Z; Ma Q
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():407-415. PubMed ID: 28672255
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive metabolomics and lipidomics profiling uncovering neuroprotective effects of
Liu LW; Yue HY; Zou J; Tang M; Zou FM; Li ZL; Jia QQ; Li YB; Kang J; Zuo LH
Front Pharmacol; 2022; 13():1076960. PubMed ID: 36618950
[No Abstract] [Full Text] [Related]
38. Study on the Multitarget Synergistic Effects of Kai-Xin-San against Alzheimer's Disease Based on Systems Biology.
Guo S; Wang J; Wang Y; Zhang Y; Bi K; Zhang Z; Li Q
Oxid Med Cell Longev; 2019; 2019():1707218. PubMed ID: 31976026
[TBL] [Abstract][Full Text] [Related]
39. Metabolic pathways involved in Xin-Ke-Shu protecting against myocardial infarction in rats using ultra high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Liu YT; Jia HM; Chang X; Cheng WH; Zhao X; Ding G; Zhang HW; Cai DY; Zou ZM
J Pharm Biomed Anal; 2014 Mar; 90():35-44. PubMed ID: 24321516
[TBL] [Abstract][Full Text] [Related]
40. Characterization of brain-derived extracellular vesicle lipids in Alzheimer's disease.
Su H; Rustam YH; Masters CL; Makalic E; McLean CA; Hill AF; Barnham KJ; Reid GE; Vella LJ
J Extracell Vesicles; 2021 May; 10(7):e12089. PubMed ID: 34012516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
